Therapeutic Asset Ratings

Cyclophosphamide

Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4)

Fludarabine

Idarubicin

Irinotecan

Naltrexone

(+)-Vincristine

Vincristine Sulfate

10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one

(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone

4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-

Abiraterone

Adriamycin

Albumin Aggregated

Alogliptin

Amino Acids, Branched-Chain

Anastrozole

Anastrozole

Apixaban

Atorvastatin

Azacitidine

Bendamustine

Bendamustine

Bortezomib

Bortezomib